Status and phase
Conditions
Treatments
About
To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.
Full description
To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.Test various indicatorsbefore test, 4 weeks, 12 weeks and 24 weeks.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
240 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Jun Li, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal